Brokerage firms Nuvama, CLSA, and Macquarie have highlighted strong growth prospects for TCS, Bajaj Finance, and IRCTC, ...

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Dr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate ...

Of this, the startup has already pocketed $10 Mn from Nuvama Private Wealth and a US-based VC firm will infuse another $10 Mn ...

Buoyed by signs of early demand revival, the management of TCS guided for stronger growth in CY25 and FY26 versus that seen ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Avenue Supermarts, operator of DMart, is expected to report an 18% YoY revenue growth to Rs 16,016 crore for Q3FY25, with net ...

Tata Consultancy Services have 'Buy' ratings from brokers despite mixed Q3 FY25 results; discover insights on stock ...

India's economy is experiencing subdued demand and slower growth across sectors due to weak household incomes and sluggish ...

Expects catering services revenues to grow at 15% CAGR over next three years. Key growth levers: Higher share of reserved ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...